Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Aquablation Effective for Treating Benign Prostatic Obstruction

By HospiMedica International staff writers
Posted on 16 Sep 2019
Waterjet ablation can relieve benign prostatic obstruction (BPO) in men with small- to medium-sized glands, according to a new study.

Researchers at Clinique Pasteur (Toulouse, France), and the University of Limoges (France) conducted a study involving 30 patients referred for BPO and benign prostate hyperplasia (BPH) surgical management. More...
The aquablation procedure was performed using the Procept BioRobotics (Redwood Shores, CA, USA) Aquabeam system, which combines transrectal prostatic image guidance and robotics tissue resection with a high-pressure saline jet. The surgeon first defines the area of treatment, and the resection is executed automatically.

The results showed that median operative time was 30.5 minutes, and median resection time was four minutes. The International Prostate Symptom Score (IPSS) score improved to three (on a scale of six) at six months; IPSS improvements persisted for a year. Maximum urinary flow and post-void residual (PVR) also showed significant improvement, especially among men with an elevated PVR at baseline. Erectile function decreased slightly or remained stable, and 26.7% of the men had ejaculatory dysfunction at follow-up. The study was published on July 4, 2019, in European Urology.

“One has to keep in mind that the more the urologist will relieve the prostatic obstruction, the more durable will be the urinary improvement, but to the detriment of ejaculatory function,” said lead author urologist Vincent Misrai, MD, of Clinique Pasteur. “More and more patients want nowadays to balance between lower-urinary-tract symptoms and sexuality when the time comes for the surgery.”

Prostate resection with Aquablation therapy combines an integrated cystoscope with intra-operative ultrasound. Personalized treatment planning is undertaken on the AquaBeam Robot monitor to map the exact treatment contour. Using the transverse and sagittal ultrasound views of the prostate, the surgeon adjusts the length, sweep angle and depth of treatment, thus defining treatment 3D boundaries while sparing the anatomical landmarks responsible for continence and ejaculatory function. The AquaBeam Robotic System then autonomously executes the treatment plan, resecting the identified prostate tissue with a heat-free, high-velocity waterjet.

Related Links:
Clinique Pasteur
University of Limoges
Procept BioRobotics


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Premium Air-Mattress
MA-51
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.